Kimberly M Ken, Mariah M Johnson, Justin J Leitenberger, Donald E Neal, Jeremy R Etzkorn, Panayiota Govas, Bryan T Carroll, Ahmed H Badawi, Tejaswi Mudigonda, M Laurin Council, Christina Avila, David R Carr, Jodie Sasaki, Travis W Blalock, Nicholas J Golda,
<h4>Background</h4>Dermatologic surgery is associated with low postoperative infection rates, averaging from approximately 1% to 4.25%. Often, postoperative infections are treated empirically based on clinical diagnosis of infection, given it can take 48 to 72 hours for a wound culture to identify a pathogen.<h4>Objective</h4>We aimed to evaluate the efficacy of empiric ... Read more >>
Dermatol Surg (Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.])
[2020, 46(10):1294-1299]
Cited: 0 times
Ahmed H Badawi, Vikas Patel, Ann E Warner, John C Hall,
Cutis (Cutis)
[2020, 106(2):E15-E17]
Cited: 0 times
Daniel J Aires, Jo Wick, Tarek S Shaath, Anand N Rajpara, Vikas Patel, Ahmed H Badawi, Cicy Li, Garth R Fraga, Gary Doolittle, Deede Y Liu,
New melanoma drugs bring enormous benefits but do so at significant costs. Because melanoma grows deeper and deadlier over time, deeper lesions are costlier due to increased sentinel lymph node biopsy, chemotherapy, and disease-associated income loss. Prior studies have justified pigmented lesion biopsies on a "value per life" basis; by ... Read more >>
J Drugs Dermatol (Journal of drugs in dermatology : JDD)
[2016, 15(5):527-532]
Cited: 4 times
Ahmed H Badawi, Paul Kiptoo, Teruna J Siahaan,
Most of the current therapies used in the treatment of multiple sclerosis (MS) are either ineffective or have adverse side effects. As such, there is a need to develop better therapies that specifically target myelin-specific aberrant immune cells involved in CNS inflammation without compromising the general immune system. In the ... Read more >>
J Mult Scler (Foster City) (Journal of multiple sclerosis)
[2015, 2(1):]
Cited: 4 times
Ahmed H Badawi, Kimberly Tefft, Garth R Fraga, Deede Y Liu,
Acute generalized exanthematous pustulosis (AGEP) is an abrupt cutaneous adverse reaction usually in response to medications. It is generally a self-limiting disease if diagnosed promptly and the offending agent discontinued. Cetirizine, a commonly used anti-histamine medication for the treatment of allergic diseases has few reported side effects and is normally ... Read more >>
Dermatol Online J (Dermatology online journal)
[2014, 20(5):22613]
Cited: 4 times
Ahmed H Badawi, Selina Gierer, Garth R Fraga,
A 48-year-old man with typical features of Schnitzler Syndrome is presented, followed by a discussion of the pathogenesis and clinical aspects of this rare disease. Some of the challenges we and others have faced in diagnosing and treating this disease are also discussed. Clinical pearls and pitfalls are emphasized to ... Read more >>
Allergy Asthma Proc (Allergy and asthma proceedings)
[2014, 35(1):75-77]
Cited: 3 times
Ahmed H Badawi, Teruna J Siahaan,
Previously, bifunctional peptide inhibitors (BPI) with a single antigenic peptide have been shown to suppress experimental autoimmune encephalomyelitis (EAE) in an antigen-specific manner. In this study, a multivalent BPI (MVBMOG/PLP) with two antigenic peptides derived from myelin oligodendrocyte glycoprotein (MOG38-50) and myelin proteolipid protein (PLP139-151) was evaluated in suppressing MOG38-50- ... Read more >>
J Neuroimmunol (Journal of neuroimmunology)
[2013, 263(1-2):20-27]
Cited: 9 times
Ahmed H Badawi, Paul Kiptoo, Wen-Tung Wang, In-Young Choi, Phil Lee, Charlotte M Vines, Teruna J Siahaan,
The efficacy of bifunctional peptide inhibitor (BPI) in preventing blood-brain barrier (BBB) breakdown during onset of experimental autoimmune encephalomyelitis (EAE) and suppression of the disease was evaluated in mice. The mechanism that defines how BPI prevents the disease was investigated by measuring the in vitro cytokine production of splenocytes. Peptides were ... Read more >>
Neuropharmacology (Neuropharmacology)
[2012, 62(4):1874-1881]
Cited: 18 times
Barlas Büyüktimkin, Prakash Manikwar, Paul K Kiptoo, Ahmed H Badawi, John M Stewart, Teruna J Siahaan,
The objective of this work is to utilize novel I-domain antigenic-peptide conjugates (IDAC) for targeting antigenic peptides to antigen-presenting cells (APC) to simulate tolerance in experimental autoimmune encephalomyelitis (EAE). IDAC-1 and IDAC-3 molecules are conjugates between the I-domain protein and PLP-Cys and Ac-PLP-Cys-NH(2) peptides, respectively, tethered to N-terminus and Lys ... Read more >>
Mol Pharm (Molecular pharmaceutics)
[2013, 10(1):297-306]
Cited: 2 times
Ahmed H Badawi, Teruna J Siahaan,
Multiple sclerosis (MS) is a neurodegenerative disease in which the immune system recognizes proteins of the myelin sheath as antigenic, thus initiating an inflammatory reaction in the central nervous system. This leads to demyelination of the axons, breakdown of the blood-brain barrier, and lesion formation. Current therapies for the treatment ... Read more >>
Clin Immunol (Clinical immunology (Orlando, Fla.))
[2012, 144(2):127-138]
Cited: 13 times
Sumit Majumdar, Bimo A Tejo, Ahmed H Badawi, David Moore, Jeffrey P Krise, Teruna J Siahaan,
The objective of this work is to test the hypothesis that increasing the hydrophilicity of DOX-peptide conjugates may modify their entry mechanisms into HL-60 cells from passive diffusion to receptor-mediated uptake. To test this hypothesis, the entry mechanisms and the intracellular disposition of DOX-cIBR7, DOX-PEGcIBR7, FITC-cIBR, and FITC-cIBR7 were evaluated ... Read more >>
Mol Pharm (Molecular pharmaceutics)
[2009, 6(2):396-406]
Cited: 5 times